Lucentis 0.5 MG/0.05ML
Ended Awarded
- Contract number
- SPE2DR26FBTBU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,345
Award facts
- Contract value 100% obligated
- $3,345.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,345.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL. This delivery order, issued without a set-aside designation, is scheduled for completion by November 21, 2025, and represents a routine pharmaceutical procurement to support Department of Defense medical supply needs. DMS Pharmaceutical Group operates as a critical supplier within the federal pharmaceutical supply chain and maintains an established track record of delivering diverse pharmaceutical products and medical consumables to DoD healthcare facilities.
This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The underlying PPV-G GEN V represents a $30.3 billion acquisition strategy designed to consolidate pharmaceutical sourcing across the DoD's global military healthcare operations through regional prime vendor arrangements. As an authorized delivery order under this indefinite delivery contract, the Lucentis procurement exemplifies the routine fulfillment of specialized pharmaceutical requirements for military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FBTBU?
SPE2DR26FBTBU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FBTBU worth?
The government has obligated $3,345 on SPE2DR26FBTBU.
Is contract SPE2DR26FBTBU an order under another contract?
Yes. SPE2DR26FBTBU is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTBU competed?
The extent of competition for SPE2DR26FBTBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award